This study will investigate the molecular mechanisms of atypical-antipsychotic induced insulin resistance. This will be accomplished by administering olanzapine or placebo to healthy subjects for 7 days and analyzing genetic and protein changes in peripheral tissues known to play an important role in insulin resistance pathophysiology.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
31
atypical antipsychotic
placebo control
Wayne State University Clinical Research Center
Detroit, Michigan, United States
Change in DNA methylation
Change in peripheral tissue candidate gene methylation will be measured in the olanzapine intervention group compared to placebo
Time frame: Baseline (day 1) to endpoint of intervention (day 7)
Change in protein levels
Change in peripheral tissue candidate protein levels will be measured in the olanzapine intervention group compared to placebo
Time frame: Baseline (day 1) to endpoint of intervention (day 7)
Change in protein activity
Change in peripheral tissue candidate protein phosphorylation will be measured in the olanzapine intervention group compared to placebo
Time frame: Baseline (day 1) to endpoint of intervention (day 7)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.